Safety Evaluation of the MiniMed 670G System in Children 7–13 Years of Age with Type 1 Diabetes

Objective: To evaluate the safety of in-home use of the MiniMed™ 670G system with SmartGuard™ technology in children with type 1 diabetes (T1D). Methods: Participants (N = 105, ages 7–13 years, mean age 10.8 ± 1.8 years) were enrolled at nine centers (eight in the United States and one in Israel) an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Technol Ther
Main Authors: Forlenza, Gregory P., Pinhas-Hamiel, Orit, Liljenquist, David R., Shulman, Dorothy I., Bailey, Timothy S., Bode, Bruce W., Wood, Michael A., Buckingham, Bruce A., Kaiserman, Kevin B., Shin, John, Huang, Suiying, Lee, Scott W., Kaufman, Francine R.
Formato: Artigo
Idioma:Inglês
Publicado em: Mary Ann Liebert, Inc., publishers 2019
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6350071/
https://ncbi.nlm.nih.gov/pubmed/30585770
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/dia.2018.0264
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados